Press + news
August 25, 2020
Codex DNA Demonstrates Momentum Toward Mission of Building World’s First Vaccine Printer and Global Vaccine Network
The Digital-to-Biological Converter will enable printing life-saving vaccines on a global scale using synthetic DNA to stop future pandemics
August 18, 2020
Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use
The new BioXp™ 3250 system – a fully automated, benchtop platform for synthetic biology workflows – dramatically accelerates the development of critical new vaccines and biologics
July 16, 2020
Codex DNA Releases New Synthetic SARS-CoV-2 Genome for COVID-19 Vaccine and Therapeutic Research
New version represents dominant variant of the virus responsible for COVID-19 to enable relevant research and development of clinical treatments
April 9, 2020
Codex DNA announces 8 new products to support the scientific community’s battle against COVID-19
Pioneering synthetic DNA company releases a wide range of antigen panels, synthetic DNA parts, and vaccine scaffolds to expedite vaccine development, drug discovery, and diagnostics
April 6, 2020
SGI-DNA is now Codex DNA
Pioneering DNA synthesis company — inventor of the Gibson Assembly® method and the BioXp™ system — furthers its mission to empower researchers in moving “from reading DNA to writing and printing DNA”
February 18, 2020
SGI-DNA Equipping Researchers With Critical Tools to Combat Coronavirus Disease (COVID-2019)
Synthetic biology company taking major steps in worldwide effort to put a stop to the SARS-CoV-2 (formerly known as 2019-nCoV) outbreak, including co-funding purchases of BioXp™ 3200 System. SGI-DNA is enabling researchers to quickly print DNA required to discover vaccines and therapeutics.
January 31, 2020
SGI-DNA Launches Vmax™ X2, the Most Innovative Product in the Competent Cells Market Since the Discovery of E. coli
Pioneering synthetic biology company, SGI-DNA, releases a new protein expression system, accelerating research into vaccines and personalized medicines by delivering up to 4x more soluble protein than traditional E. coli methods in half the time.
December 23, 2019
SGI-DNA Appoints Brian Donnelly as Chief Commercial Officer
As we enter the most critical year in our company’s history—2020, we are pleased to announce that Brian Donnelly is joining our team as Chief Commercial Officer.
November 19, 2019
SGI-DNA Launches Gibson Assembly® RapidAMP™ Technology for its BioXp™ Gene Builder
The technology allows for mammalian transfection-ready DNA constructs to be synthesized, assembled into custom vectors, and amplified in a single day on the BioXp™ Gene Builder, eliminating the need to clone and copy DNA in E. coli.
October 1, 2019
Gibson Assembly® Advances Field of DNA Digital Data Storage
Gibson Assembly® strategy successfully employed to significantly increase the throughput of DNA data storage and retrieval.
September 9, 2019
SGI-DNA Secures $25 Million Series A Financing to Support Commercial Launch
Company using capital for the global commercial launch of the BioXp™ 3200 system — a fully automated gene synthesis and cloning platform powered by Gibson Assembly® Technology — and execution of its product roadmap for automated printing of biological materials and DNA data storage.
August 26, 2019
SGI-DNA Launches Multi-Tile Assembly Cloning (MTAC) Application for its BioXp™ 3200 Gene Builder
Multi-fragment cloning application leverages Gibson Assembly® technology to advance automated protein and antibody engineering capabilities and custom vector printing.